Dr Carmel Moore

Carmel is experienced in research study coordination, with a track record in successful delivery of wide-ranging research projects including community- and NHS-based randomised controlled trials and cross-sectional studies. 

[email protected]

Background

Carmel started her role as Clinical Trials Coordinator at the Anglia Ruskin Clinical Trials Unit in August 2019. The work within the CTU involves working with clinical/academic collaborators on each stage of the research process from bid development to publication to ensure data are captured and reported in accordance with regulatory requirements to produce high-quality research.

Carmel gained her PhD at Institute of Food Research, Reading University. She previously worked as a Research Scientist in the Nutrition and Health Research Group at MRC Human Nutrition Research, and a Senior Scientific Co-ordinator at Cardiovascular Epidemiology Unit, University of Cambridge. Her roles have involved working on a wide range of research projects (including large, randomised controlled trials). She has experience in preparing successful grant applications, obtaining relevant regulatory approvals, developing study protocols, monitoring, compiling essential study documents, and writing/contributing to reports and scientific publications.

Area of expertise:

• Research study design, set up, and delivery

Research interests

• Clinical trials

Qualifications

• PhD, Institute of Research, Reading University 
• BSc (Hons) Food and Consumer Science, University of North London

Selected recent publications

Radakovic R, Copsey H, Moore C and Mioshi E (2020). Development of the MiNDToolkit for management of cognitive and behavioural impairment in motor neuron disease. Neurodegenerative Disease management https://doi.org/10.2217/nmt-2019-0035

Kaptoge S, Di Angelantonio E, Moore C….Thompson SG on behalf of the INTERVAL Trial Group (2019). Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors. Lancet Haematology 6:e510-20

Di Angelantonio E, Thompson SG, Kaptoge S, Moore C, Walker M, Armitage J, Ouwehand WH, Roberts DJ and Danesh J on behalf of the INTERVAL Trial Group (2017). Efficiency and safety of varying the frequency of whole blood donation: randomised trial of 45,000 donors. Lancet 390(10110): 2360

Moore C, Bolton T, Walker M, ……Thompson SG (2016). Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals. Trials 17:458